Buprenorphine prescription remained constant during the first year of COVID-19 pandemic

Science Instruments in laboratory room. Science Research Concept.

The number of active prescriptions for the opioid disorder treatment drug buprenorphine remained constant during the first year of the COVID-19 pandemic, but the number of new prescriptions for the treatment was far below what would normally have been expected, according to a new RAND Corporation study.

Researchers detect the Alongshan virus for the first time in Swiss ticks

Previous article

Liver cancer study could help improve the safety of certain gene therapies for hemophilia

Next article

You may also like


Leave a reply

Your email address will not be published. Required fields are marked *

More in News